{{Rsnum
|rsid=4926831
|Gene=AGBL4
|Chromosome=1
|position=49824429
|Orientation=plus
|GMAF=0.3131
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=AGBL4
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 22.1 | 42.5 | 35.4
| HCB | 94.2 | 5.8 | 0.0
| JPT | 79.6 | 20.4 | 0.0
| YRI | 87.8 | 10.9 | 1.4
| ASW | 61.4 | 31.6 | 7.0
| CHB | 94.2 | 5.8 | 0.0
| CHD | 98.2 | 1.8 | 0.0
| GIH | 39.6 | 48.5 | 11.9
| LWK | 77.3 | 21.8 | 0.9
| MEX | 29.3 | 53.4 | 17.2
| MKK | 55.1 | 37.2 | 7.7
| TSI | 18.6 | 46.1 | 35.3
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs4926831
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363810
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4926831
|overall_frequency_n=42
|overall_frequency_d=128
|overall_frequency=0.328125
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=38
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}